Repeatability and methodology of resting energy expenditure in patients with cystic fibrosis

被引:9
作者
Bell, SC
Elborn, JS
Nixon, LE
Macdonald, IA
Shale, DJ
机构
[1] Univ Wales Coll Med, Llandough Hosp, Sect Resp Med, Llandough Hosp, Penarth, S Glam, Wales
[2] Univ Wales Coll Med, Llandough Hosp, Sect Resp Med, Community NHS Trust, Penarth, S Glam, Wales
[3] Queens Med Ctr, Dept Physiol & Pharmacol, Nottingham NG7 2UH, England
来源
RESPIRATION PHYSIOLOGY | 1999年 / 115卷 / 03期
关键词
disease; cystic fibrosis; pseudomonas aeruginosa; energy; expenditure; resting; gas exchange; mammals; humans;
D O I
10.1016/S0034-5687(99)00008-0
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
In this study, intra-individual variation of resting energy expenditure (REE) in adults with cystic fibrosis (CF) and the effect of measurement duration were determined. Twelve adults with CF and chronic Pseudomonas aeruginosa (Ps. aeruginosa) infection and 12 healthy volunteers, matched for age and sex were studied whilst clinically stable on days 1, 2, and 15. Respiratory gas exchange was monitored by continuous measurement of oxygen uptake ((V) over dot (O2)) and carbon dioxide production ((V) over dot (CO2)) using a ventilated hood indirect calorimeter. Coefficients of variation (CVs) were 4.3% in patients and 2.4% in controls comparing days 1 and 2. The CV for patients was 5.0% and for controls 2.9% comparing days I and 15. The effect of measurement duration on REE was assessed in eight of the CF patients. REE remained stable for 40 min but tended to rise by 80 min. Plasma catecholamine concentrations were stable between study days in patients but fell with time in controls suggesting some adaptation to experimental procedure. The seater variability of REE in patients was related to change in serum CRP over 2 weeks. REE is a repeatable measurement in clinically stable patients with CF, though variability was greater in patients than healthy subjects. This has implications for the design and interpretation of longitudinal studies of REE in patients with chronic lung disease. (C) 1999 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 18 条
[1]   EFFECTS OF ADMINISTRATION OF AEROSOLIZED RECOMBINANT HUMAN DEOXYRIBONUCLEASE ON RESTING ENERGY-EXPENDITURE IN PATIENTS WITH CYSTIC-FIBROSIS [J].
AMIN, N ;
DOZOR, AJ .
PEDIATRIC PULMONOLOGY, 1994, 18 (03) :150-154
[2]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[3]   INCREASED RESTING ENERGY-EXPENDITURE IN CYSTIC-FIBROSIS [J].
BUCHDAHL, RM ;
COX, M ;
FULLEYLOVE, C ;
MARCHANT, JL ;
TOMKINS, AM ;
BRUETON, MJ ;
WARNER, JO .
JOURNAL OF APPLIED PHYSIOLOGY, 1988, 64 (05) :1810-1816
[4]   C-REACTIVE PROTEIN MEASURED IN DRIED BLOOD SPOTS FROM PATIENTS WITH CYSTIC-FIBROSIS [J].
CORDON, SM ;
ELBORN, JS ;
HILLER, EJ ;
SHALE, DJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 1991, 143 (01) :69-72
[5]  
ECCLES MP, 1989, EUR J CLIN NUTR, V43, P485
[6]   TUMOR-NECROSIS-FACTOR-ALPHA, RESTING ENERGY-EXPENDITURE AND CACHEXIA IN CYSTIC-FIBROSIS [J].
ELBORN, JS ;
CORDON, SM ;
WESTERN, PJ ;
MACDONALD, IA ;
SHALE, DJ .
CLINICAL SCIENCE, 1993, 85 (05) :563-568
[7]   AN AUTOMATED-METHOD FOR THE MEASUREMENT OF OXYGEN-CONSUMPTION AND CARBON-DIOXIDE EXCRETION IN MAN [J].
FELLOWS, IW ;
MACDONALD, IA .
CLINICAL PHYSICS AND PHYSIOLOGICAL MEASUREMENT, 1985, 6 (04) :349-355
[8]   RESTING ENERGY-EXPENDITURE IN INTERSTITIAL LUNG-DISEASE [J].
FITTING, JW ;
FRASCAROLO, P ;
JEQUIER, E ;
LEUENBERGER, P .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1990, 142 (03) :631-635
[9]   MEASUREMENT OF RESTING ENERGY-EXPENDITURE IN A CLINICAL SETTING [J].
FREDRIX, EWHM ;
SOETERS, PB ;
VONMEYENFELDT, MF ;
SARIS, WHM .
CLINICAL NUTRITION, 1990, 9 (06) :299-304
[10]  
GARBY L, 1984, CLIN NUTR, V38, P395